Daré Bioscience
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $187 | $152 | $1,023 | $2 |
Gross Profit | -132 | -644 | 727 | -1,172 |
EBITDA | -2,953 | -2,245 | -907 | -3,080 |
EBIT | -2,800 | -1,441 | -3,562 | |
Net Income | -2,982 | -2,999 | -1,441 | -3,562 |
Net Change In Cash | 187 | 152 | 1,023 | 2 |
Free Cash Flow | -6,855 | -5,520 | 1,237 | -616 |
Cash | 12,617 | 18,519 | 24,711 | 23,075 |
Basic Shares | 14,889 | 14,522 | 14,499 | 12,755 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,030 | $9 | $2,807 | $10,000 |
Gross Profit | -1,416 | -14,295 | -18,830 | 10,000 |
EBITDA | -10,425 | -4,011 | -30,701 | -31,361 |
EBIT | -12,576 | -4,053 | -30,739 | -31,385 |
Net Income | -13,399 | -4,053 | -30,161 | 406,802 |
Net Change In Cash | 1,030 | 9 | 2,807 | 10,000 |
Free Cash Flow | -10,271 | 4,821 | -39,486 | -18,151 |
Cash | 24,711 | 15,698 | 10,476 | 34,669 |
Basic Shares | 111,787 | 8,497 | 7,275 | 7,048 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.20 |
2026-03-31 | -$0.20 |
2025-12-31 | -$0.10 |
2025-09-30 | -$0.28 |